LightDark Log in Sign up

‹ Back to screener

INDGN.NS Indegene Ltd.

Healthcare

Price history

2025-08-21 ₹572.85
2026-08-21 ₹565.50
Change over window -1.28%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 55.6%
Trailing 20-day average 57.8%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 1891693 1050880 55.55%
2026-08-27 464592 289568 62.33%
2026-08-26 374825 224796 59.97%
2026-08-25 197235 117734 59.69%
2026-08-24 258087 143062 55.43%
2026-08-21 364708 218404 59.88%
2026-08-20 1256695 996399 79.29%
2026-08-19 302162 155684 51.52%
2026-08-18 161896 104193 64.36%
2026-08-17 174182 106671 61.24%
2026-08-14 285759 160610 56.20%
2026-08-13 336818 216122 64.17%
2026-08-12 439544 272946 62.10%
2026-08-11 1020394 607599 59.55%
2026-08-10 1362509 763562 56.04%
2026-08-07 963198 467351 48.52%
2026-08-06 3351725 1955482 58.34%
2026-08-05 745330 453041 60.78%
2026-08-04 1047239 416249 39.75%
2026-08-03 1886714 791315 41.94%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers INDGN.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
24 Mar 2026 Anita Nair Immediate relative Buy Market Purchase 22230 9998248 0.10% XBRL
04 Mar 2026 Sameer Narendrakumar Lal Other Sell Market Sale 60000 29203513 0.22% XBRL
18 Nov 2025 Sameer Narendra Lal - Sell Market Sale 10000 5125695 0.24% XBRL
14 Nov 2025 BINA PATIL - Sell Market Sale 500 262850 0.12% XBRL
14 Nov 2025 BINA PATIL - Sell Market Sale 5930 3105455 0.11% XBRL
14 Nov 2025 BINA PATIL - Sell Market Sale 2000 1031700 0.11% XBRL
14 Nov 2025 BINA PATIL - Sell Market Sale 13570 6984909 0.11% XBRL
14 Nov 2025 AMIT GUPTA - Sell - 2200 1137088 0.00% XBRL
14 Nov 2025 AMIT GUPTA - Sell - 2200 1137088 0.00% XBRL
14 Nov 2025 AMIT GUPTA - Sell - 2200 1137088 0.00% XBRL
13 Nov 2025 BINA SANJEEV PATIL - Sell Market Sale 5930 3107320 0.12% XBRL
13 Nov 2025 BINA SANJEEV PATIL - Sell Market Sale 500 262850 0.12% XBRL
13 Nov 2025 BINA SANJEEV PATIL - Sell Market Sale 2000 1031699 0.12% XBRL
08 Sep 2025 Rajesh Bhaskaran Nair Director Buy Market Purchase 9150 4997768 7.16% XBRL
27 Dec 2024 Manish Gupta Director Buy Market Purchase 17000 10186185 8.97% XBRL
23 Dec 2024 Sanjay Suresh Parikh Employees/Designated Employees Buy Market Purchase 16500 10007649 5.02% XBRL
23 Dec 2024 Rajesh Bhaskaran Nair Employees/Designated Employees Buy Market Purchase 25000 14956597 7.19% XBRL
18 Dec 2024 Rajesh Bhaskaran Nair Director Buy Market Purchase 100000 59580954 7.17% XBRL
05 Dec 2024 Viveksheel A. Ghai Employees/Designated Employees Sell Market Sale 20000 12552741 0.22% XBRL
28 Sep 2024 Suhas Prabhu Key Managerial Personnel Sell Market Sale 49380 33054953 0.31% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers INDGN.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹567.80 INR (live) · fetched 2026-08-24 01:38 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Ratios

P/E
34.05
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹567.80 / (₹4,011,000,000 / 240,500,000 shares) = ₹567.80 / ₹16.68 EPS
FY2025-26 · Annual filing
ROE
12.78%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹4,011,000,000 / ₹31,387,000,000 = 12.78%
FY2025-26 · Annual filing
Debt/Equity
0.00
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹0 / ₹31,387,000,000 = 0.00
FY2025-26 · Annual filing
Current Ratio
2.41
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹26,184,000,000 / ₹10,862,000,000 = 2.41
FY2025-26 · Annual filing
ROCE
17.99%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹5,646,000,000 / (₹31,387,000,000 + ₹0) = 17.99%
FY2025-26 · Annual filing
Dividend Yield
0.35%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹480,000,000 / 240,500,000 shares) / ₹567.80 = ₹2.00 / ₹567.80
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 2.0y actual) 16.4%
Net Profit (3y) 7.9%
Revenue (5y, 2.0y actual) 16.4%
Net Profit (5y) 7.9%
Revenue (10y, 2.0y actual) 16.4%
Net Profit (10y) 7.9%

Operating Margin Trend

Eroding

FY2023-24 19.5%
FY2024-25 19.8%
FY2025-26 16.1%

ROCE Trajectory

FY2023-24 27.6%
FY2024-25 21.5%
FY2025-26 18.0%

Earnings Quality

Needs net profit and CFO for 3+ stored years; only 2 on file.

Sector-Relative Percentile (Healthcare)

ROE 39th
ROCE 54th
Debt/Equity 100th
P/E 74th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹673.00 Cr. ₹676.50 Cr. ₹686.80 Cr. ₹720.40 Cr. ₹755.60 Cr. ₹760.80 Cr. ₹804.20 Cr. ₹942.10 Cr. ₹1,003.40 Cr. ₹1,063.10 Cr. RevenueFromOperations
Net Profit ₹96.60 Cr. incl. minority ₹94.80 Cr. ₹87.70 Cr. ₹91.70 Cr. ₹109.70 Cr. ₹117.60 Cr. ₹116.40 Cr. ₹102.10 Cr. ₹102.90 Cr. ₹79.70 Cr. ₹116.20 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers INDGN.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent4011000000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital240500000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets26184000000.0
CurrentLiabilities10862000000.0
EquityAttributableToOwnersOfParent31387000000.0
BorrowingsCurrent + BorrowingsNoncurrent

My notes